Day Zero Diagnostics: Funding, Investors & Team (Oct 2026)
Day Zero is revolutionizing infectious disease diagnostics by using advanced technologies like whole-genome sequencing and their own proprietary methods. They aim to generate clinically actionable data on a large scale and create a new class of sequencing-based in-vitro diagnostics. Their innovative sample preparation techniques allow for highly accurate sequencing of pathogen DNA directly from clinical samples. They also utilize machine learning algorithms to provide diagnostic results that are clinically useful. Additionally, they have built a top-notch database of whole-genome sequencing and drug effectiveness profiles. The goal of Day Zero Diagnostics is to transform how infectious disease diagnostics are carried out by providing real-time sequencing data that can help track, manage, and combat these diseases. Their initial focus is on bloodstream infections and sepsis, where quick antibiotic treatment is critical to a patient's survival. Current diagnostic methods take several days to identify the pathogen and determine its susceptibility to antibiotics, leaving physicians to rely on broad-spectrum antibiotics that may be ineffective and harmful. Day Zero, on the other hand, can provide a complete diagnosis within hours, including both the identification of the pathogen and its antibiotic resistance profile. This allows physicians to administer targeted treatments from the very beginning, resulting in better patient outcomes and cost savings.
Day Zero Diagnostics has raised $24.2M across 2 funding rounds on record, the most recent an undisclosed round of $16.0M announced in Sep 2023.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Day Zero Diagnostics Company Profile and Key Stats
Latest funding round on record: Sep 2023.
Day Zero Diagnostics Funding Rounds
Day Zero Diagnostics raised $8.2M in a Grant announced in Oct 2022.
11 months later, an undisclosed round of $16.0M was announced in Sep 2023.
Day Zero Diagnostics Founders and Leadership Team
Contact details for the Day Zero Diagnostics team: 1 of 1 has an email address on file.
Start 14-day free trial →Day Zero Diagnostics Funding Compared to Other Biotechnology Startups
Day Zero Diagnostics' latest round of $16.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Day Zero Diagnostics in Biotechnology and Boston
Companies Similar to Day Zero Diagnostics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Day Zero Diagnostics Funding FAQs
What does Day Zero Diagnostics do?
Day Zero is revolutionizing infectious disease diagnostics by using advanced technologies like whole-genome sequencing and their own proprietary methods. They aim to generate clinically actionable data on a large scale and create a new class of sequencing-based in-vitro diagnostics. Their innovative sample preparation techniques allow for highly accurate sequencing of pathogen DNA directly from clinical samples. They also utilize machine learning algorithms to provide diagnostic results that are clinically useful. Additionally, they have built a top-notch database of whole-genome sequencing and drug effectiveness profiles. The goal of Day Zero Diagnostics is to transform how infectious disease diagnostics are carried out by providing real-time sequencing data that can help track, manage, and combat these diseases. Their initial focus is on bloodstream infections and sepsis, where quick antibiotic treatment is critical to a patient's survival. Current diagnostic methods take several days to identify the pathogen and determine its susceptibility to antibiotics, leaving physicians to rely on broad-spectrum antibiotics that may be ineffective and harmful. Day Zero, on the other hand, can provide a complete diagnosis within hours, including both the identification of the pathogen and its antibiotic resistance profile. This allows physicians to administer targeted treatments from the very beginning, resulting in better patient outcomes and cost savings.
How much funding has Day Zero Diagnostics raised?
Day Zero Diagnostics has raised $24.2M across 2 rounds on record. The most recent is an undisclosed round of $16.0M announced in Sep 2023.
When did Day Zero Diagnostics last raise funding?
Day Zero Diagnostics' most recent funding round on record is an undisclosed round of $16.0M, announced in Sep 2023.
Who is the CEO of Day Zero Diagnostics?
Jong Lee is listed as CEO at Day Zero Diagnostics.
Where is Day Zero Diagnostics headquartered?
Day Zero Diagnostics is based in Boston, Massachusetts, United States.
How many employees does Day Zero Diagnostics have?
Day Zero Diagnostics is in the 11-50 employee band.
How does Day Zero Diagnostics' funding compare to other Biotechnology startups?
Day Zero Diagnostics' latest round of $16.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Day Zero Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Day Zero Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.